Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × idecabtagene vicleucel × 30 days × Clear all

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Specimen Handling 118 Magnetic Resonance Spectroscopy 104 Biopsy 79 pembrolizumab 70 Carboplatin 64 Cyclophosphamide 55 Paclitaxel 49 Cisplatin 49 Radiotherapy 43 Nivolumab 42 Gemcitabine 40 Lenalidomide 35 Dexamethasone 35 Radiation 33 durvalumab 31 atezolizumab 29 Prednisone 29 Ipilimumab 29 Doxorubicin 29 Pemetrexed 28 Fluorouracil 27 Bevacizumab 27 olaparib 26 Rituximab 26 venetoclax 25 Vincristine 24 Taxes 24 Oxaliplatin 23 Etoposide 22 Docetaxel 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06045806 2026-03-05

KarMMa-9

Celgene

Phase 3 Active not recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡